SLC19A1 polymorphism and serum methotrexate in patients with acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a common pediatric malignancy. Methotrexate is the widely used chemotherapy for ALL. The polymorphism (rs1051296) of SLC19A1 is proposed for its effect on serum methotrexate. To explain this observation, the authors hereby studied the interrelationship between S...
Saved in:
| Main Authors: | Beuy Joob, Viroj Wiwanitkit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=1;spage=120;epage=121;aulast=Joob |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between ABCB1 C3435 T polymorphism- and methotrexate-related toxicity in pediatric acute lymphoblastic leukemia: a meta-analysis
by: Xuefen Yan, et al.
Published: (2025-12-01) -
High-Dose Methotrexate: Treatment Experience in Patient with B-cell Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Avinash Khadela, et al.
Published: (2021-01-01) -
Prognostic impact of clinical and genetic factors on delayed elimination of methotrexate in children with acute lymphoblastic leukemia
by: O. D. Gurieva, et al.
Published: (2025-01-01) -
The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
by: T. T. Valiev, et al.
Published: (2024-12-01) -
Effect of folate status and methylenetetrahydrofolate reductase genotypes on the complications and outcome of high dose methotrexate chemotherapy in north Indian children with acute lymphoblastic leukemia
by: Nirmalya Roy Moulik, et al.
Published: (2016-01-01)